The Ohio State University Wexner Medical Center The James Cancer Hospital and Solove Research Institute
Welcome,         Profile    Billing    Logout  
 10 Trials 
21 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Brenner, Lisa Anne
Apollo PTSD, NCT05019651: Acceptability and Feasibility of Apollo in Veterans With a History of PTSD

Completed
2
63
US
Apollo Wearable System
Lisa Brenner, Apollo Neuroscience
PTSD
06/23
06/23
NCT06375083: Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression

Recruiting
2
472
US
Cognitive Behavioral Therapy
VA Eastern Colorado Health Care System
Suicide, Depression
12/24
12/24
NCT04150380: Probiotic (LGG) for Veterans With PTSD

Recruiting
2
150
US
Lactobacillus rhamnosus GG (LGG; ATCC strain 53103; CRMTS #11272; PTS #3766), Placebo
VA Eastern Colorado Health Care System, University of Colorado, Denver, University of Colorado, Boulder
Post Traumatic Stress Disorder, Inflammation
12/24
12/25
XTX202-01, NCT05052268 / 2022-003078-21: XTX202 in Patients With Advanced Solid Tumors

Active, not recruiting
1/2
189
US
XTX202
Xilio Development, Inc., Xilio Development, Inc
Advanced Solid Tumor
02/26
02/26
SGNS70-101, NCT04227847: A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies

Recruiting
1
140
Europe, US
SEA-CD70, azacitidine, VIDAZA
Seagen Inc.
Myelodysplastic Syndrome, Acute Myeloid Leukemia
12/24
11/26
AMC-105, NCT04139304: A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Active, not recruiting
1
15
US
Cyclophosphamide, (-)-Cyclophosphamide, 2H-1,3,2-Oxazaphosphorine, 2-[bis(2-chloroethyl)amino]tetrahydro-, 2-oxide, monohydrate, Carloxan, Ciclofosfamida, Ciclofosfamide, Cicloxal, Clafen, Claphene, CP monohydrate, CTX, CYCLO-cell, Cycloblastin, Cycloblastine, Cyclophospham, Cyclophosphamid monohydrate, Cyclophosphamide Monohydrate, Cyclophosphamidum, Cyclophosphan, Cyclophosphane, Cyclophosphanum, Cyclostin, Cyclostine, Cytophosphan, Cytophosphane, Cytoxan, Fosfaseron, Genoxal, Genuxal, Ledoxina, Mitoxan, Neosar, Revimmune, Syklofosfamid, WR- 138719, Daratumumab, Anti-CD38 Monoclonal Antibody, Darzalex, HuMax-CD38, JNJ-54767414, Doxorubicin, Adriablastin, Hydroxydaunomycin, Hydroxyl Daunorubicin, Hydroxyldaunorubicin, Doxorubicin Hydrochloride, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)- (9CI), ADM, Adriacin, Adriamycin, Adriamycin Hydrochloride, Adriamycin PFS, Adriamycin RDF, ADRIAMYCIN, HYDROCHLORIDE, Adriamycine, Adriblastina, Adriblastine, Adrimedac, Chloridrato de Doxorrubicina, DOX, DOXO-CELL, Doxolem, Doxorubicin HCl, Doxorubicin.HCl, Doxorubin, Farmiblastina, FI 106, FI-106, hydroxydaunorubicin, Rubex, Etoposide, Demethyl Epipodophyllotoxin Ethylidine Glucoside, EPEG, Lastet, Toposar, Vepesid, VP 16, VP 16-213, VP-16, VP-16-213, VP16, Prednisone, .delta.1-Cortisone, 1, 2-Dehydrocortisone, Adasone, Cortancyl, Dacortin, DeCortin, Decortisyl, Decorton, Delta 1-Cortisone, Delta-Dome, Deltacortene, Deltacortisone, Deltadehydrocortisone, Deltasone, Deltison, Deltra, Econosone, Lisacort, Meprosona-F, Metacortandracin, Meticorten, Ofisolona, Orasone, Panafcort, Panasol-S, Paracort, Perrigo Prednisone, PRED, Predicor, Predicorten, Prednicen-M, Prednicort, Prednidib, Prednilonga, Predniment, Prednisone Intensol, Prednisonum, Prednitone, Promifen, Rayos, Servisone, SK-Prednisone, Vincristine, LEUROCRISTINE, VCR, Vincrystine, Vincristine Sulfate, Kyocristine, Leurocristine sulfate, Leurocristine, sulfate, Oncovin, Vincasar, Vincosid, Vincrex, Vincristine, sulfate
AIDS Malignancy Consortium, National Cancer Institute (NCI), Janssen Scientific Affairs, LLC, Montefiore Medical Center, Memorial Sloan Kettering Cancer Center, AIDS and Cancer Specimen Resource, The Emmes Company, LLC
Plasmablastic Lymphoma, Ann Arbor Stage I Diffuse Large B-Cell Lymphoma, Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
07/25
08/27
FAAST, NCT04159480: Facilitating Assessment of At-Risk Sailors Using Technology

Completed
N/A
279
US
Experimental - Cogito Companion, Active Control
VA Eastern Colorado Health Care System, University of Colorado, Denver, Military Suicide Research Consortium
Psychological Distress
03/23
03/23
CU-REST, NCT05683145: University of Colorado - Restoring Efficient Sleep After TBI

Recruiting
N/A
80
US
Computerized Cognitive Behavioral Therapy for Insomnia
VA Eastern Colorado Health Care System, Colorado Traumatic Brain Injury Trust Fund, University of Colorado, Denver
Insomnia, Traumatic Brain Injury
06/24
12/24
LOWFLC, NCT06630728: Addiction Potential of Very Low Nicotine Filtered Little Cigars

Not yet recruiting
N/A
30
US
Reduced Nicotine Content Cigars, Normal nicotine content cigar, Usual brand cigar
Ohio State University Comprehensive Cancer Center
Smoking (Tobacco) Addiction
12/27
01/28
NCT05510908: Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Recruiting
N/A
720
US
Non-Interventional, Non-Interventional Follow-up
AIDS Malignancy Consortium, National Cancer Institute (NCI)
HIV-Associated Malignant Neoplasm, HIV Infections, Cancer, AIDS Related Lymphoma, AIDS-related Kaposi Sarcoma, AIDS-Related Malignancy, Anal Cancer, HPV-Related Malignancy
11/25
09/26
NCT01334476: VISN 19 MIRECC Research Database

Recruiting
N/A
5000
US
VA Eastern Colorado Health Care System
Demographic Data, History of Medical and Mental Health, History of Combat Experience, History of Suicide, Imaging Results
03/26
03/26
RESEC, NCT05869318: Respiratory Effects of E-Cigarettes in Obese Youth

Recruiting
N/A
70
US
ECIG own, ECIG Vuse
Ohio State University Comprehensive Cancer Center
E-Cig Use
12/26
12/27
Verschraegen, Claire
Neo-DREAM, NCT03567889 / 2021-003064-27: Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C Melanoma Patients

Recruiting
3
186
Europe, US
Daromun, Surgery, Adjuvant therapy
Philogen S.p.A., Philogen S.p.A.
Melanoma Stage IIIB/C
06/24
06/26
NCT03944941: Avelumab with or Without Cetuximab in Treating Patients with Advanced Skin Squamous Cell Cancer

Active, not recruiting
2
60
US
Avelumab, Cetuximab
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Skin Squamous Cell Carcinoma, Metastatic Skin Cancer
11/26
12/28
ARTACUS, NCT04349436: A Phase 1B/2 Study of RP1 in Solid Organ Transplant Patients With Advanced Cutaneous Malignancies

Recruiting
1/2
65
US
RP1, intra-tumoral injection, oncolytic virus
Replimune Inc.
Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma, Basal Cell Carcinoma, Melanoma
09/27
01/28
NCI-2018-03329, NCT03798639: Nivolumab and Radiation Therapy or Ipilimumab as Adjuvant Therapy in Treating Patients With Merkel Cell Cancer

Completed
1
7
US
Ipilimumab, Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody, BMS-734016, MDX-010, MDX-CTLA4, Yervoy, Nivolumab, BMS-936558, MDX-1106, NIVO, ONO-4538, Opdivo, Radiation Therapy, Cancer Radiotherapy, Irradiate, Irradiated, irradiation, Radiation, Radiotherapeutics, RADIOTHERAPY, RT, Therapy, Radiation
Claire Verschraegen
Merkel Cell Carcinoma, Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8, Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8
12/22
12/22
NCT04137900: Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

Recruiting
1
499
US
TAB004, JS004, Toripalimab, TAB001, JS001
TopAlliance Biosciences, Shanghai Junshi Bioscience Co., Ltd., CTI Clinical Trial and Consulting Services
Advanced Unresectable Solid Tumor, Metastatic Solid Tumor
03/26
03/26
Yixing, Jiang
NCT04137900: Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

Recruiting
1
499
US
TAB004, JS004, Toripalimab, TAB001, JS001
TopAlliance Biosciences, Shanghai Junshi Bioscience Co., Ltd., CTI Clinical Trial and Consulting Services
Advanced Unresectable Solid Tumor, Metastatic Solid Tumor
03/26
03/26
Kleiber, Barbara
NCT05624918: A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma

Recruiting
2
38
US
Nab paclitaxel, Abraxane, Gemcitabine, Gemzar, NovoTTF-200T(P), TTFields
Ashish Manne, NovoCure GmbH, Ohio State University
Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer
08/27
08/28
NCT04658147: Feasibility and Efficacy of Perioperative Nivolumab With or Without Relatlimab for Patients With Potentially Resectable Hepatocellular Carcinoma (HCC)

Recruiting
1
20
US
Nivolumab, OPDIVO™, BMS 936558, MDX1106, ONO-4538, Relatlimab, BMS-986016, BMS-986016-01, Anti-LAG-3
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Bristol-Myers Squibb
Hepatocellular Carcinoma
06/25
06/26
NCT04137900: Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies

Recruiting
1
499
US
TAB004, JS004, Toripalimab, TAB001, JS001
TopAlliance Biosciences, Shanghai Junshi Bioscience Co., Ltd., CTI Clinical Trial and Consulting Services
Advanced Unresectable Solid Tumor, Metastatic Solid Tumor
03/26
03/26

Download Options